Predicted protein targets (top 14)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 2/20 | 0.32 |
| ▸ | MEN1 | O00255 | 1/20 | 0.32 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.32 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.32 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.32 |
| ▸ | HPGD | P15428 | 2/20 | 0.31 |
| ▸ | MAPT | P10636 | 1/20 | 0.31 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.31 |
| ▸ | TSHR | P16473 | 1/20 | 0.31 |
| ▸ | CASP1 | P29466 | 1/20 | 0.31 |
| ▸ | CASP7 | P55210 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL25819053 | 0.94 | PLA2G2A (0.32) | ALDH1A1KDM4EHSD17B10KMT2AHPGD | |
| SCHEMBL24618527 | 0.91 | HTT (0.33) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL25038163 | 0.89 | PLA2G2A (0.33) | ALDH1A1KDM4EHSD17B10MEN1KMT2A | |
| SCHEMBL25038124 | 0.89 | HTT (0.32) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL25035862 | 0.89 | MAPT (0.33) | ALDH1A1KDM4EHSD17B10MEN1KMT2A | |
| SCHEMBL25879221 | 0.89 | PLA2G2A (0.34) | ALDH1A1KDM4EHSD17B10MEN1KMT2A | |
| SCHEMBL25878376 | 0.89 | HTT (0.34) | ALDH1A1KDM4EMEN1KMT2ASMN1; SMN2 | |
| SCHEMBL25878391 | 0.88 | PLA2G2A (0.36) | ALDH1A1KDM4EHSD17B10MEN1KMT2A | |
| SCHEMBL25818217 | 0.86 | KDM4E (0.31) | ALDH1A1KDM4EHSD17B10HPGDMAPT | |
| SCHEMBL25878879 | 0.86 | HCRTR1 (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | SHAANXI LIGHTE OPTOELECTRONICS MATERIAL CO., LTD. (CN) | 2023-07-06 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230217825-A1 | ORGANIC COMPOUND, AND ELECTRONIC ELEMENT AND ELECTRONIC DEVICE USING SAME | OR10J3, AOC2, EPCAM | ALDH1A1 489/4885KDM4E 1669/4885HSD17B10 2817/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.